|
|
|
Insider
Information: |
Tapiero Jacques |
Relationship: |
Director |
City: |
Indianapolis |
State: |
IN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
85,914 |
|
Indirect Shares
|
21,034 |
|
|
Direct
Value |
$50,065,251 |
|
|
Indirect Value
|
$18,211,658 |
|
|
Total
Shares |
106,948 |
|
|
Total
Value |
$68,276,909 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-75.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Eli Lilly & Co |
LLY |
SVP&Pres., Emerging Ma... |
2014-01-28 |
55,384 |
2014-01-28 |
21,034 |
Premium* |
|
McCormick & Co Inc |
MKC |
Director |
2024-04-22 |
30,530 |
2012-12-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
82 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LLY |
Eli Lilly & Co |
SVP&Pres.-Emerging Markets BUO |
|
2010-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
12,181 |
|
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres.-Emerging Markets BUO |
|
2010-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,212 |
|
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres.-Emerging Markets BU |
|
2010-01-26 |
4 |
A |
$36.16 |
$538,133 |
D/D |
14,882 |
21,094 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2010-02-17 |
4 |
S |
$34.35 |
$68,700 |
D/D |
(2,000) |
19,094 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2010-03-11 |
4 |
S |
$35.40 |
$141,625 |
D/D |
(4,000) |
15,094 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2010-03-15 |
5 |
GD |
$0.00 |
$0 |
D/D |
3,738 |
11,356 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2010-03-15 |
5 |
GA |
$0.00 |
$0 |
I/I |
3,738 |
14,328 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2011-01-25 |
4 |
A |
$34.73 |
$578,949 |
D/D |
16,670 |
28,026 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2011-03-04 |
4 |
S |
$34.50 |
$172,500 |
D/D |
(5,000) |
23,026 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2011-04-12 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,878 |
18,206 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2011-04-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,878 |
19,148 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2011-10-01 |
4 |
D |
$36.97 |
$188,806 |
D/D |
(5,107) |
26,541 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2011-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
31,648 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2011-11-18 |
4 |
S |
$36.88 |
$184,400 |
D/D |
(5,000) |
21,541 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2012-01-26 |
4 |
A |
$39.44 |
$206,547 |
D/D |
5,237 |
26,869 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2012-03-12 |
4 |
AS |
$39.60 |
$79,200 |
D/D |
(2,000) |
24,869 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2012-04-17 |
4 |
AS |
$40.00 |
$80,000 |
D/D |
(2,000) |
22,869 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2012-05-14 |
4 |
AS |
$41.04 |
$82,080 |
D/D |
(2,000) |
20,869 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2012-06-14 |
4 |
AS |
$41.60 |
$88,400 |
D/D |
(2,125) |
18,744 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2012-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
31,244 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2012-10-01 |
4 |
D |
$47.41 |
$220,125 |
D/D |
(4,643) |
26,601 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2013-01-25 |
4 |
A |
$53.21 |
$1,049,993 |
D/D |
19,733 |
46,334 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2013-01-30 |
4 |
S |
$54.14 |
$812,100 |
D/D |
(15,000) |
31,334 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2013-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,649 |
48,983 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP&Pres., Emerging Markets |
|
2013-02-01 |
4 |
D |
$53.69 |
$439,238 |
D/D |
(8,181) |
40,802 |
0 |
- |
|
82 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|